Long
10/5/22 RVNC
Revance Therapeutics, Inc.($NASDAQ:RVNC)
Sector: Health Technology (Pharmaceuticals: Major)
Market Capitalization: $2.124B
Current Price: $29.17
Breakout price: $30.00
Buy Zone (Top/Bottom Range): $27.45-$24.15
Price Target: $41.10-$42.00
Estimated Duration to Target: 132-142d
Contract of Interest:
RVNC 1/20/23 30c
Trade price as of publish date: $3.70/contract
Sector: Health Technology (Pharmaceuticals: Major)
Market Capitalization: $2.124B
Current Price: $29.17
Breakout price: $30.00
Buy Zone (Top/Bottom Range): $27.45-$24.15
Price Target: $41.10-$42.00
Estimated Duration to Target: 132-142d
Contract of Interest:
RVNC 1/20/23 30cTrade price as of publish date: $3.70/contract
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.